We focus on serving the special needs of participants in traditional and emerging life sciences markets, including biotechnology, pharmaceuticals, medical devices, diagnostics, contract research and laboratory services, agricultural biotechnology and drug discovery tools.  Wyrick Robbins has been top-listed in North Carolina for Biotechnology Law by Best Lawyers in America the last five years.  Additionally, our firm was ranked No. 1 in the Southeast and No. 16 nationally for venture capital deals by Dow Jones Private Equity Analyst.

The primary types of legal services our Life Sciences Industry Team provides to clients include:

• general counsel services (company formation, board advisory, employee and consulting agreements, equity compensation plans, office and lab space leasing);
• corporate finance and M&A (seed and angel financings, private placements, venture capital and private equity financings, M&A transactions, public offerings);
• licensing and corporate partnerships (licenses, complex research collaborations, option agreements, joint ventures, co-promotion, co-marketing arrangements); and
• industry contract drafting and negotiation (CDA,  MTA, SRA, CRADA, CSA, manufacturing and supply and distribution).

In meeting the legal needs of our clients, our industry teams call upon our various practice areas for areas of particular legal expertise. Our life sciences clients include a large variety of start-up and venture-backed companies, spin-outs from research universities and larger corporations, public companies and venture capital firms. To view a representative list of Life Sciences Industry Team clients, click here.

For additional information, please contact our Life Sciences Industry Team leader, Ken Eheman, at (919) 865-2804 or keheman@wyrick.com.